Notify me when TomEnterprise AB files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| DMAC | DiaMedica Therapeutics Inc. | Common Shares, no par value | 16% | $32,695,950 | 8,383,577 | TomEnterprise AB | 23 Jul 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|